CD163 and breast cancer: A high density of M1 macrophages expressing iNOS in the center of the tumor, together with high presence of CD8+ cells, has been associated with improved survival in HER2+ breast cancer; in contrast, the presence of CD163+ macrophages and T-reg cells was linked to poor prognosis [17].